InflaRx
Price & Volume
Stats
See more52W Range | $1.13-$2.81 |
Market Cap | $79.8M |
Shares Short | 386,342 |
Financials
See moreRevenue (12 Mos) | $168,498 |
Revenue Growth (YoY) | 103.6% |
Gross Profit (12 Mos) | -$604,767 |
Diluted EPS | -$1.07 |
News
See moreYahoo Finance • 19 days ago
InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences
Yahoo Finance • 26 days ago
InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Yahoo Finance • 30 days ago
InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Yahoo Finance • last month
InflaRx Announces Public Offering of Ordinary Shares and Pre-Funded Warrants
About
CEO | Dr. Niels C. Riedemann M.D., Ph.D. |
Address | Winzerlaer Str. 2, Jena, Germany, 07745 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 62 |
